Sun Exposure

Strict sun avoidance and unchecked tanning are both wrong answers. Long-term cohort data show that people who avoid the sun die earlier — mostly from heart disease and internal cancers — while people who burn or accumulate severe skin damage die earlier from melanoma and accelerated aging. The optimum is short, frequent, sub-burning exposure to a lot of skin, with sunscreen reserved for longer outdoor stretches.

The traditional dermatological position has been "the safest sun is no sun," and it stands up well for one outcome: melanoma and non-melanoma skin cancer scale roughly with cumulative UV dose. But long-running European cohorts — and now multidimensional UV-exposure analyses inside the UK Biobank — have made it clear that strict avoidance is itself a measurable risk factor for all-cause, cardiovascular, and internal-cancer mortality. The mortality curve is J-shaped: low exposure is bad, very high exposure is bad, and a non-burning middle is best.

What the evidence actually supports

Strong:

Strict sun avoidance is independently associated with higher all-cause mortality. The Melanoma in Southern Sweden (MISS) cohort followed nearly 30,000 women for ~20 years; avoiders had roughly double the mortality of the highest-exposure group, and regular sunbathing vacations carried a 30% lower all-cause mortality (HR 0.70)^[1].
The mortality curve is J-shaped. Severe physician-graded actinic skin damage (a marker of cumulative excess UV) carries an ~45% higher all-cause mortality (HR ~1.45). Strict avoidance and sunburn-level overexposure are both worse than moderate, non-burning sun^[2].
Cumulative UV is the dominant driver of skin aging. Wrinkling, solar elastosis, lentigines, and the leathery photoaged phenotype come from UV-driven matrix-metalloproteinase (MMP-1, -3, -9) activation degrading dermal collagen — not from chronological aging^[3]^[4].
UVB-driven cutaneous vitamin D synthesis is the human default. Diet contributes a small fraction of typical vitamin D status; without sun or supplements, deficiency is the rule at temperate latitudes^[5].

Moderate:

UVA-driven nitric-oxide release lowers blood pressure. Skin holds large stores of nitrogen-oxide species that UVA mobilises into bioactive nitric oxide; population blood pressure tracks with latitude and season, and a cohort of 342,457 dialysis patients across 2,178 US clinics found incident UV linearly inversely associated with pre-dialysis systolic blood pressure^[6]^[7].
UV exposure activates a real skin-brain axis. Keratinocytes synthesise CRH, POMC, β-endorphin, and serotonin locally on UV exposure; circulating β-endorphin from sun exposure produces measurable opioid-like effects, and animal models show pharmacological-naloxone–reversible withdrawal after chronic UV^[8]^[9].
Bright morning sun anchors the circadian clock. Daylight intensity at the eyes (via melanopsin-expressing retinal cells) suppresses morning melatonin and sets the evening melatonin rise. This is the single highest-leverage cue for sleep timing — see Circadian rhythms.

Weak / preliminary:

Non-classical UVB photoproducts (lumisterol, tachysterol) act through alternative nuclear receptors (AhR, LXR, ROR) and appear photoprotective and anti-inflammatory in mechanistic and cell-culture work. Whether this matters clinically — i.e., whether sun-derived vs. oral vitamin D differ in long-term outcomes — is unsettled.
Oral systemic photoprotectants — Polypodium leucotomos extract (PLE), astaxanthin, oral nicotinamide — show mechanistic and short-trial signal for reducing photoaging and actinic damage, but are not substitutes for sunscreen^[10].

Caution:

Tanning beds, solarium use, and any history of sunburn sharply elevate melanoma risk and should be treated as straightforwardly harmful.
Familial melanoma, dense dysplastic nevi, very pale skin (Fitzpatrick I/II), or immunosuppression: there is no known "safe" intentional UV dose. Vitamin D status should be managed via oral supplementation, not sun^[11].

The mortality J-curve

The evidence base on sun and mortality has shifted because the methodology improved. Early cohorts approximated lifetime UV exposure with proxies like birth year — which conflates UV with everything else that changed across the 20th century (indoor work, diet, smoking, screening intensity). The MISS cohort improved on that with structured sun-habit interviews. UK Biobank's Sun-BEEM index now blends self-reported habits, occupation, latitude history, and physician-graded actinic damage into a quantitative individual exposure measure^[12].

The picture across these analyses is consistent:

Outcome	Moderate, non-burning UV	Sunburn / chronic excess	Strict avoidance
All-cause mortality	Lower	Higher	Higher
Cardiovascular mortality	Lower	Mixed	Higher
Internal cancers	Lower	Mixed	Higher
Cutaneous melanoma	Neutral / slight protection (steady exposure)	Sharply higher	Lower
Non-melanoma skin cancer	Higher with cumulative dose	Sharply higher	Lower

Skin-cancer risk and mortality risk move in opposite directions. For a population without high melanoma genetic risk, the net mortality balance favours moderate exposure^[13].

Why sun-derived vitamin D is not the same as a pill

Cutaneous vitamin D synthesis is a photochemical cascade: UVB (~290–315 nm) opens the B-ring of 7-dehydrocholesterol in epidermal keratinocyte and fibroblast membranes, generating previtamin D3, which thermally isomerises to cholecalciferol over hours. The molecule is then released slowly to the bloodstream bound to vitamin-D-binding protein (DBP).

Three differences from oral D3 matter:

Sustained kinetics. Sun-derived D3 enters the circulation slowly and ride DBP, which gives it 2–3× the effective serum half-life of an equivalent oral dose. Oral D3 is absorbed via the gut into chylomicrons and lipoproteins and clears in roughly a day.
No toxicity ceiling. Excess UVB photodegrades surplus previtamin D3 into lumisterol and tachysterol — sun cannot cause hypervitaminosis D. Oral D3, by contrast, can.
Local epidermal supply. Keratinocytes are poorly vascularised and don't reliably import DBP-bound systemic D from the bloodstream; they rely on their own UV-driven synthesis to drive antimicrobial-peptide production, differentiation, and DNA-repair signalling. Oral supplementation does not fully reach this compartment^[14].

Lumisterol and tachysterol, long dismissed as inert byproducts, are increasingly recognised as bioactive ligands for AhR, LXR, and ROR receptors with photoprotective and anti-inflammatory effects in skin. Whether this translates to differences in clinical outcomes between sun-derived and supplemented vitamin D is not yet established.

Practical implication. Maintain a steady serum 25(OH)D across the year. At Czech / Central European latitudes (~50°N) endogenous synthesis is essentially zero from roughly October through March, so oral vitamin D3 across the winter is the standard fix — see Core supplement stack. Do not try to "bank" D in summer by deliberate overexposure — the photodegradation fail-safe means extra burning yields extra skin damage, not extra D^[15].

Cardiovascular and metabolic effects independent of vitamin D

UVA is the longer-wavelength, less DNA-damaging part of the spectrum, and it does something distinct: it photolyses cutaneous nitrogen-oxide stores into bioactive nitric oxide (NO), which diffuses systemically and triggers arterial vasodilation. This is the most plausible mechanism behind the latitude and seasonal blood-pressure gradients seen in dozens of populations: BP peaks in winter and falls in summer roughly independently of temperature^[16].

The effect is substantial enough to be visible in a 342,457-patient hemodialysis cohort with daily clinic BP recordings: incident UV was inversely and linearly associated with pre-dialysis systolic blood pressure after adjustment for ambient temperature, age, sex, and BMI^[17].

UV exposure also tracks with lower LDL-cholesterol, lower CRP and IL-6, and (in animal models) suppression of high-fat-diet–induced obesity that oral vitamin D does not reproduce^[18]. The implication is that low vitamin D in obese, hypertensive populations is partly a biomarker of UV deprivation rather than the upstream cause of their metabolic disease — and giving them a pill replaces only one of the things they're missing.

Mood, sleep, and the skin-brain axis

UV-exposed keratinocytes locally synthesise corticotropin-releasing hormone (CRH) → proopiomelanocortin (POMC) → β-endorphin, α-MSH, and ACTH; the skin has its own functional analogue of the hypothalamic-pituitary-adrenal axis. The β-endorphin reaches the systemic circulation and binds μ-opioid receptors centrally — which is why frequent sun exposure produces measurable opioid-like analgesia and mood elevation, and why naloxone reliably triggers withdrawal in UV-habituated mice^[19]^[20].

The skin also generates serotonin from tryptophan independently of the central serotonin system. Cutaneous serotonin synthesis falls in winter, contributing to the seasonal-pattern depression (formerly SAD) signature^[21].

For sleep specifically: bright morning sunlight at the eyes is the highest-leverage circadian zeitgeber. The retinohypothalamic tract carries this signal to the suprachiasmatic nucleus, which sets the evening melatonin rise that allows sleep onset 14–16 hours later. The dose that matters is daytime brightness (10,000+ lux outdoors vs. 100–500 lux indoors), not UV per se — see Circadian rhythms.

What UV actually does to skin

The visible signs of "old skin" — coarse wrinkling, leathery texture, sagging, lentigines, telangiectasias — are mostly photoaging, not chronological aging. Compare sun-protected skin (e.g., the underside of an upper arm) with sun-exposed skin (the back of the same hand) in any 70-year-old: the difference is the cumulative UV history.

Mechanism. UV photons drive an immediate burst of reactive oxygen species in the epidermis and upper dermis. ROS activate MAP-kinase signalling, which upregulates the AP-1 and NF-κB transcription factors. Those in turn:

Massively upregulate MMP-1 (interstitial collagenase) — cleaves type I/III fibrillar collagen, the dermis's main load-bearing protein.
Upregulate MMP-3 (stromelysin-1) — breaks down proteoglycans and fibronectin, and activates other latent MMPs.
Upregulate MMP-9 (gelatinase B) — finishes off the fragmented collagen pieces.
Down-regulate fibroblast procollagen synthesis at the same time, producing a structural deficit^[22].

UV also covalently modifies the surviving collagen — irreversible carbonylation at proline, arginine, and lysine residues, which disrupts fibroblast adhesion and contractile function. The matrix doesn't just thin; it stops working.

UVA penetrates deeply into the dermis and is the dominant driver of these changes. UVB penetrates less but causes most of the direct DNA damage (cyclobutane pyrimidine dimers) and is the dominant driver of skin cancer.

Repair runs on a clock. Nucleotide excision repair (NER) — the system that excises UV-induced DNA lesions — is itself circadian, with peak capacity at specific phases of the 24-hour cycle. UV exposure at hours of low NER activity (deep evening, night — e.g., tanning beds) measurably amplifies the per-photon mutagenic load^[23]. Solar UV during normal daytime hours hits the body when DNA repair is most active.

Skin type changes everything

The Fitzpatrick scale tracks the eumelanin / pheomelanin balance. Lighter skin (Types I–III) is heavier in pheomelanin, which is a pro-oxidant under UV and amplifies free-radical damage. Darker skin (Types IV–VI) is heavier in eumelanin, a broad-spectrum filter and antioxidant.

Two practical numbers:

Innate SPF. Type I/II skin has an intrinsic SPF of about 3.3. Type V/VI skin has roughly 13.4. Eumelanin functions as built-in sunscreen.
Vitamin D synthesis time. A Fitzpatrick V/VI individual needs roughly 5–10× the UVB exposure of a Type II individual to make the same amount of vitamin D. Blanket sun-avoidance guidelines apply this 10× penalty without compensating with stronger oral repletion advice — which is part of why severe vitamin D deficiency is endemic in dark-skinned populations at temperate latitudes^[24].

The 2024 Australian/NZ revised position statement formalises this with three risk groups^[25]:

Very high skin-cancer risk — Fitzpatrick I/II, immunosuppression, melanoma history, dense dysplastic nevi. Year-round photoprotection; manage vitamin D with supplements.
High vitamin-D-deficiency risk, low skin-cancer risk — Fitzpatrick V/VI. Routine daily sunscreen during ordinary outdoor activity is discouraged; deliberate brief unprotected exposure to maintain vitamin D status is appropriate.
Intermediate — most of the population. Sub-erythemal exposure during incidental outdoor activity for systemic benefit; sunscreen for longer outdoor stretches and high UV index.

Practical guidance

Aim for micro-doses, not "tans"

The conversion of 7-dehydrocholesterol to previtamin D3 saturates quickly. Past that plateau, additional UV adds skin damage without adding vitamin D. The biologically efficient form is brief exposures of a lot of skin, repeated, not long exposures of small areas^[26].

A reasonable rule of thumb, for an intermediate skin type at midday with arms and legs uncovered:

UV index	Approximate exposure for vitamin D
1–2 (low)	Synthesis is slow; sunscreen rarely needed
3–5 (moderate)	15–20 min
6–7 (high)	10–15 min
8–10 (very high)	5–7 min
11+ (extreme)	< 5 min; high erythema risk, avoid direct mid-sun

Spread these across the week; do not "stack" exposure. Time between sessions is what lets nucleotide excision repair clear UV-induced DNA lesions before they accumulate.

Protect when exposure exceeds the synthesis dose

Once you're past the brief vitamin-D / NO window — long beach days, alpine hiking, sustained outdoor work — the calculation flips and the goal is photoprotection.

Broad-spectrum sunscreen (UVA + UVB). SPF 30–50 is sufficient for most skin types; SPF 50+ for Fitzpatrick I/II or with melanoma history. Daily incidental sunscreen does not measurably lower vitamin D status in randomised trials.
Hat, long sleeves, UV-blocking sunglasses. UV-driven cataracts, macular degeneration, and pterygium are real and largely preventable.
Avoid sunburn. This is the single most useful bright line. Burning is what tracks with melanoma risk; sub-erythemal exposure largely does not.
No tanning beds, ever. Their UV profile is not the daytime spectrum, exposure is at hours of low NER activity, and the risk-benefit balance is straightforwardly negative.

Oral systemic photoprotection — useful but adjunctive

A small, mechanistically coherent literature supports oral Polypodium leucotomos extract (PLE), astaxanthin, and oral nicotinamide as adjunct photoprotectants. PLE preserves cutaneous vitamin D receptor levels under oxidative stress via NRF2; nicotinamide supports the ATP-intensive NER repair process and modestly reduces non-melanoma skin cancer in high-risk patients^[27]^[28]. These are useful additions for high-exposure days; they are not substitutes for sunscreen or for not burning.

Cautions and contraindications

Personal or strong family history of melanoma, dense dysplastic nevi, prior skin cancer, immunosuppression, photosensitising medications (some antibiotics, retinoids, amiodarone, NSAIDs, etc.): treat sun primarily as a hazard. Get a yearly dermatology check; manage vitamin D with supplements.
Pregnancy: moderate, non-burning sun is fine and relevant for vitamin D status. Avoid melasma triggers — Fitzpatrick III–V skin pigments aggressively under sun + hormones.
Eye health: the lens absorbs most UVB; chronic UVA exposure is the macular-degeneration and cataract risk. Real UV-blocking sunglasses are cheap and worth wearing on bright days.
Children: their thinner stratum corneum and higher remaining lifetime dose make burn-prevention the dominant priority; sub-erythemal play in the sun is fine and useful for vitamin D.

What's overrated

"Sunscreen causes vitamin D deficiency." It can, in theory, but doesn't measurably do so under normal daily-use patterns in randomised trials. Most population deficiency is from indoor lifestyles and high latitude, not from sunscreen.
Tanning as a longevity strategy. Tans are visible UV damage; they are not the source of the cardiovascular and mood benefits of sun, which appear at sub-erythemal doses long before tanning.
"You can store vitamin D in summer for winter." The half-life of 25(OH)D is several weeks; a Czech-latitude summer cannot cover a Czech-latitude winter. Use oral D3 across the dark months — see Core supplements.
Oral D as a full substitute for sun. It restores systemic 25(OH)D but doesn't reproduce UVA-driven nitric oxide, the skin-brain axis, daytime circadian entrainment, or the local epidermal vitamin D supply. Useful, necessary at temperate latitudes — but not a complete replacement.